Use of polymethylmethacrylate plaque as a treatment of cranioschisis associated with meningocele in a Girolando heifer: A case report / Uso de placa de polimetilmetacrilato (PMMA) no tratamento de craniosquise associada à meningocele em uma bezerra girolando: relato de caso

Most genetic diseases affect purebred animals and are inherited as recessive genes. Cranioschisis refers to dysraphism, which occurs in the midline of the skull due to failure to close the cranial symphysis, which can lead to herniation of the meninges filled with cerebrospinal fluid (meningocele), where there is usually a projection of the meningeal tissue. Diagnosis is performed based on clinical examination, characteristic anatomopathological data, and complementary imaging tests. The surgical approach for correction of cranioschisis is the only described as a therapeutic solution and is indicated in cases in which the cranial synthesis defect does not allow for brain protrusion and there is only the occurrence of meningocele, in addition to the absence of severe signs of neurological alteration. This paper reports a case of the use of polymethylmethacrylate (PMMA) plaque to treat cranioschisis associated with meningocele in a Girolando heifer. The surgical opening of the frontonasal sacculation allowed draining a total liquid content of 488 mL, inspection, and suture of the envelope membrane. APMMA plaque, molded to the bone surface and anchored in the adjacent soft tissue, was used to cover the evidenced frontonasal bone opening. Despite the unfavorable prognosis of the disease, the cranioplasty surgery for the treatment of cranioschisis associated with meningocele using PMMA plaque obtained satisfactory results relative to the quality and maintenance of this animal's life, evaluated at 19 months postoperatively.(AU)

A maioria das doenças genéticas acometem animais de raça pura e herdados como genes recessivos.Acraniosquise refere-se à disrafia, que acontece na linha média do crânio pelo não fechamento da sínfise craniana, podendo levar a herniação das meninges repletas de líquido cefalorraquidiano (meningocele), onde geralmente existe projeção do tecido meningeal. O diagnóstico é realizado a partir do exame clínico, dados anatomopatológicos característicos e através da realização de exames complementares de imagem. Como solução terapêutica, a abordagem cirúrgica para correção das craniosquises é a única descrita, e é indicada em casos em que o defeito de síntese craniana não permita a protrusão encefálica e exista a ocorrência apenas da meningocele, além da inexistência de sinais graves de alteração neurológica. O artigo relata um caso de uso de placa de polimetilmetacrilato (PMMA) no tratamento de craniosquise associada à meningocele em uma bezerra Girolando. Instituiu-se a abertura cirúrgica da saculação fronto-nasal, permitindo a drenagem de conteúdo líquido total de 488 mL, inspeção e rafia de membrana envoltória. Para recobrimento da abertura óssea fronto-nasal evidenciada, utilizou-se uma placa de polimetilmetacrilato (PMMA), moldada à superfície óssea e ancorada em tecido mole adjacente. Concluiu-se que, apesar do prognóstico desfavorável da enfermidade, a cirurgia de cranioplastia para tratamento de craniosquise associada à meningocele, com a utilização de placa de PMMA, neste caso, obteve resultados satisfatórios em relação a qualidade e manutenção da vida deste animal, avaliando-se em 19 meses pós-operatório.(AU)

Corticosteroids reduce glial fibrillary acidic protein expression in response to spinal cord injury in a fetal rat model of dysraphism.

BACKGROUND: Exposure of the spinal cord in myelomeningocele (MM) throughout gestation increases spinal injury. Astrocyte activation evidenced by glial fibrillary acidic proteins (GFAP) indicates the extent of injury. Corticosteroids modulate GFAP synthesis, but their effect in MM is unclear. The purpose of this study was to evaluate the GFAP expression in a fetal rat model of dysraphism and the effect of corticosteroid treatment on this marker and on clinical neurological disabilities. METHODS: Dysraphism was surgically created in 2 groups of 48 rat fetuses; group 1: control, and group 2: treated with corticosteroid. Each group was subdivided into fetuses with surgically created MM, controls and shams on day 18.5 of gestation (term = 22 days). Fetuses were harvested on day 21.5, examined for evidence of neurological deficits, and the following clinical parameters were registered: kyphosis, tail deformities, leg deformities, leg paralysis or paresis and pain perception. The fetuses were fixed for GFAP immunostaining. RESULTS: All fetuses with MM in group 1 presented neurological deficits and glial reactions with GFAP expression, as opposed to controls and shams. In group 2, corticosteroid treatment prevented some neurological deficits (18-25%), reducing glial response and GFAP expression. CONCLUSIONS: Experimentally induced dysraphism in the rat fetus is related to glial response and increased GFAP expression in the spinal cord. Corticoid treatment clinically improved nerve injury in some fetuses. It reduced glial reaction and GFAP expression.